Posts Tagged ‘colostrum’

2012 Olympic Games – Athletes Use Bovine Colostrum

Tuesday, March 27th, 2012

Scientists investigating natural ways to enhance athletic performance have found that bovine colostrum can massively reduce gut permeability – otherwise known as ‘leaky gut syndrome.’  Their findings, published in the March issue of the American Journal of Physiology-Gastrointestinal and Liver Physiology, could have positive implications not just for athletes but also for sufferers of heatstroke.

A research group led by Ray Playford, Professor of Medicine at Barts and The London School of Medicine and Dentistry looked at athletes who were asked to run for 20 minutes at 80 per cent of their aerobic maximum. At the end of the exercise, changes in the subjects gut leakiness were measured using urine sample – also determined were changes in the athletes’ core temperature.  Under standard conditions, gut leakiness had increased by 250 per cent and temperature had risen by 2 degrees.  However, when the group were given a drink of dairy colostrum for two weeks before the trial, the rise in gut leakiness was reduced by about 80 per cent, despite the same effort and temperature rise.

Gut disorders induced by exercise are common in runners – the body’s response to increased permeability is to clear the gut contents, giving rise to symptoms such as diarrhoea to avoid toxins from gut organisms entering the bloodstream, as these lead to heatstroke which can result in damage to the internal organs.

Professor Playford’s research identified changes in gut barrier function in laboratory studies: gut cells were cultured at normal 37 degrees body heat and at 39 degrees to replicate the temperature after exercise. The death rate of gut cells was much increased at the higher temperature yet when colostrum was added to the culture medium the rise in cell death rate was reduced by two thirds.

Professor Ray Playford said: “Athletes’ performance can be seriously diminished due to gut symptoms during heavy exercise. We have been looking at natural approaches to reduce this problem as the range of products that athletes can legitimately take is very limited. Our findings suggest colostrum may have real value in helping our athletes perform. This is a research area we are especially interested in given our proximity to the 2012 Olympic site. In addition, extremes of temperature and exercise are often suffered by armed forces in desert war scenarios and can result in heat stroke which is life threatening. Based on our results to date, our research group is also exploring products that may be useful for protecting soldiers in life threatening situations such as these.”

More information: on the benefits of  bovine colostrum and how it assists athletes is published in the March issue of American Journal of Physiology-Gastrointestinal and Liver Physiology (http://ajpgi.physiology.org/)

Significant Milestone Reached for Adult Stem Cell Therapies

Saturday, April 2nd, 2011

International Stem Cell Society Tracks 750 Adult Stem Cell Patient Cases Significant milestone reached for field and promise of adult stem cell therapies.

Portland, OR, April 02, 2011 –(PR.com)

The International Cellular Medicine Society has accomplished a significant milestone through its Stem Cell Patient Treatment Registry. Today the Society announced that the ICMS Treatment Registry has reached over 750 patient cases being tracked. As a nonprofit organization dedicated to ensuring patient safety, facilitating physician education, and providing peer oversight, this level of oversight and transparency is a significant landmark for the for the field and promise of cell based medicine. “Patient safety is the foundation of the ICMS,” said Ricardo Rodriguez, MD, a director of the ICMS and co-chair of the Medical Advisory Board. “Through best practice standards, clinic accreditation and now this sizeable pool of patient outcome and complication data, the ICMS has established itself as the premiere organization in advancing adult stem cell treatments that are based on the principals of good patient care.” Participation in the Treatment Registry is reserved for those clinics that meet the Society’s minimum standards and been reviewed by the ICMS Institutional Review Board. The 750 patients have all received autologous adult stem cell treatments and have been tracked in the ICMS Treatment Registry, a secure, web-based data collection system that tracks patient-reported outcomes and complications from patient surveys and interviews at 3, 6, and 12 months, and 2, 3, 4, 5, 10 and 20 years after the treatment. The rate of complication from these treatments has been less than 2%, and no severe adverse events have been reported.

“To have this number of patients and have a rate of complications this low speaks to the safety profile of self-donated cells,” said David Audley, the Executive Director of the ICMS.

While the ICMS has collected tremendous amounts of data, the organization is adamant about maintaining the privacy of the patients and the confidentiality of the treatment protocols. The data stored in the Registry, including the processes by which the cells are collected and administered, as well as specific patient outcomes, are secure, private and available only to the clinic, the patient and select reviewers of the ICMS. These reviewers, in turn, only access Registry data to evaluate protocols and audit patient outcomes, and are bound by strict confidentiality and nondisclosure agreements. Individual members of the ICMS have no access to either patient data or the confidential processes that clinics utilize to treat patients. The ICMS does not publish outcomes from specific clinics. The ICMS does, however, publish all unadjudicated complaints and findings resulting from investigations on reported severe adverse events. The ICMS expects the number of patients tracked to increase rapidly and significantly with the recent launch of its Stem Cell Clinic Accreditation Program. As the field of cell based medicine continues to advance and the number of clinics offering stem cell treatments around the world grows, the need for the services of the ICMS as trusted and independent authority to collect patient data and evaluate clinics will expand. More information about the ICMS Registry and Clinic Accreditation Program can be found on the ICMS Website.  See details below.

About the International Cellular Medicine Society.  The ICMS is a physician guided international 501(c)(3) nonprofit organization dedicated to patient safety and the protection of the practice of medicine and physician education through the production of global guidelines for the practice of cell based medicine. The society maintains three websites, www.cellmedicinesociety.org, focused on adult stem cell education and awareness for physicians and researchers; www.stemcellwatch.com, a portal for patient education and the collection of complaints against stem cells clinics; and www.cellregistry.org, a re-implantation registry to track the long term outcomes of adult stem cell based procedures and therapies.